CVS Gives Preferred Status to Gilead Hepatitis C Drugs

CVS Health Corp. said it would make Gilead Sciences Inc.’s hepatitis C pills the exclusive treatment option for beneficiaries on its Medicare, Medicaid and other drug benefit plans.



from WSJ.com: US Business http://ift.tt/1wdn3VJ

via IFTTT